98 related articles for article (PubMed ID: 565444)
1. Thromboembolic complications after mitral valve replacement with Hancock xenograft.
Hetzer R; Hill JD; Kerth WJ; Ansbro J; Adappa MG; Rodvien R; Kamm B; Gerbode F
J Thorac Cardiovasc Surg; 1978 May; 75(5):651-8. PubMed ID: 565444
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
3. An eight-year experience with porcine bioprosthetic cardiac valves.
Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
[TBL] [Abstract][Full Text] [Related]
4. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
5. The risk of thromboembolism and hemorrhage following mitral valve replacement. A comparative analysis between the porcine xenograft valve and Ionescu-Shiley bovine pericardial valve.
Gonzalez-Lavin L; Tandon AP; Chi S; Blair TC; McFadden PM; Lewis B; Daughters G; Ionescu M
J Thorac Cardiovasc Surg; 1984 Mar; 87(3):340-51. PubMed ID: 6700241
[TBL] [Abstract][Full Text] [Related]
6. Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery.
Almahameed ST; Khan M; Zuzek RW; Juratli N; Belden WA; Asher CR; Novaro GM; Martin DO; Natale A
J Cardiovasc Electrophysiol; 2007 Apr; 18(4):364-6. PubMed ID: 17286567
[TBL] [Abstract][Full Text] [Related]
7. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
[TBL] [Abstract][Full Text] [Related]
8. Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement.
Hill JD; LaFollette L; Szarnicki RJ; Avery GJ; Wilson RM; Gerbode F; Kerth WJ; Rodvien R
J Thorac Cardiovasc Surg; 1982 May; 83(5):718-23. PubMed ID: 6978975
[TBL] [Abstract][Full Text] [Related]
9. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement.
Stewart S; Cianciotta D; Alexson C; Manning J
J Thorac Cardiovasc Surg; 1987 Apr; 93(4):551-4. PubMed ID: 3561002
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
[TBL] [Abstract][Full Text] [Related]
11. [Replacement of the mitral and aortic valves with bioprostheses. Long-term results].
Colombo T; Cicardi C; Peronace B; Pozzi M; Gordini V; Pellegrini A
G Ital Cardiol; 1985 Oct; 15(10):974-82. PubMed ID: 4092917
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
13. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
14. Early mechanical failures of the Hancock pericardial xenograft.
Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of aortic valve replacement with a porcine xenograft without long-term anticoagulation.
Pipkin RD; Buch WS; Fogarty TJ
J Thorac Cardiovasc Surg; 1976 Feb; 71(2):179-86. PubMed ID: 1246142
[TBL] [Abstract][Full Text] [Related]
16. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
17. Late results after Starr-Edwards valve replacement in children.
Schaff HV; Danielson GK; DiDonato RM; Puga FJ; Mair DD; McGoon DC
J Thorac Cardiovasc Surg; 1984 Oct; 88(4):583-9. PubMed ID: 6482490
[TBL] [Abstract][Full Text] [Related]
18. Actuarial comparison of Hancock porcine and prosthetic disc valves for isolated mitral valve replacement.
Cohn LH; Sanders JH; Collins JJ
Circulation; 1976 Dec; 54(6 Suppl):III60-3. PubMed ID: 1033048
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
Middlekauff HR; Stevenson WG; Gornbein JA
Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation in valvular heart disease preoperatively and postoperatively.
Bodnar AG; Hutter AM
Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
